Novel heterocyclic compounds
Compound (I), or relates to a pharmaceutically acceptable salt thereof to interferon inducing agent, a therapeutic agent of the antibacterial agents, anticancer agents and immunogenic diseases containing as an active ingredient.
Abstract
The present invention relates to a heterocyclic compound, or a pharmaceutically acceptable salt thereof of formula (I): [Formula I] And (wherein, R 3 can form a heterocyclic ring or a substituted heterocyclic ring together with R 1 via the nitrogen atom), [wherein, X is a sulfur atom, an oxygen atom, -NR 3 And R 1 is an alkyl group, substituted alkyl group, an aryl group, a substituted aryl group, a heterocyclic group or substituted heterocyclic group, and R 2 is a hydrogen atom, etc., a halogen atom]; And Compound (I), or relates to a pharmaceutically acceptable salt thereof to interferon inducing agent, a therapeutic agent of the antibacterial agents, anticancer agents and immunogenic diseases containing as an active ingredient. Heterocyclic compounds, synthesis, inducing activity of interferon